Investigation of the effects of 1α,25-dihydroxyvitamin D3–supplemented electrochemotherapy on apoptosis and PI3K/PKC/NF-κB signaling pathway protein levels: an in vitro experimental study
Medical Oncology · 28.10.2026 · 43 (12)
DOI: 10.1007/s12032-026-03493-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 28.10.2026. Verfasst von Zehra Çiçek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey. zehra.cicek@sbu.edu.tr. Hauptthemen laut MEDLINE: Apoptosis, NF-kappa B, Electrochemotherapy, Calcitriol. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Research Projects Coordination Unit of Kırşehir Ahi Evran University.
Abstract (Originalsprache)
Although oxaliplatin (OXA) is widely used in the treatment of colon cancer, there is a need for more effective and safer treatment approaches due to the development of treatment-related resistance, limited therapeutic efficacy, and significant side effects. In recent years, combination therapy strategies have shown promise in cancer research due to their potential to improve chemotherapy outcomes. In this study, we aimed to evaluate the effects of OXA-based electrochemotherapy (ECT) and its supplementation with 1α,25-dihydroxyvitamin D3 on cell viability, apoptotic response, intracellular survival signaling, and energy dynamics in human colon cancer cell lines. The effects of single and combined treatment applications on cell viability were evaluated using the MTT test. Apoptotic response was analyzed by caspase-3 activity measurement and Annexin V/PI flow cytometry. Intracellular survival signaling pathways Phosphatidylinositol 3-kinase (PI3K), Protein kinase C (PKC), and Nuclear factor kappa (NF-κB) protein levels were measured using ELISA, while cellular energy status was determined by luminescence-based ATP analysis. OXA treatment alone reduced cell viability in a dose-dependent manner. 25 µM OXA treatment increased caspase-3 activity while causing a decrease in PI3K, PKC, and NF-κB protein levels. In ECT treatment, the decrease in cell viability occurred at lower OXA doses. Accordingly, the decrease in PI3K, PKC, and NF-κB protein levels was significantly lower compared to the control group. In ECT treatment with 1α,25-dihydroxyvitamin D3, the decrease in viability became more pronounced, and the IC50 value decreased from 138.66 µM for OXA alone to 26.30 µM with the combined treatment. On the other hand, survival markers PI3K, PKC, and NF-κB protein levels showed a dramatic decrease, while total ATP levels increased. In conclusion, ECT therapy supplemented with 1α,25-dihydroxyvitamin D3 significantly enhanced the cytotoxic effect compared to OXA therapy alone, by inducing caspase-3 activation and suppressing the PI3K/PKC/NF-κB signaling pathways. Furthermore, the increase in ATP levels suggests that the combined therapy may reprogram cellular energy metabolism. However, it should be noted that further molecular and in vivo studies are needed to understand the therapeutic mechanisms and sustainability of these effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey. zehra.cicek@sbu.edu.tr.
- Department of Biophysics, Department of Basic Medical Sciences, Faculty of Medicine, Kırşehir Ahi Evran University, Kırşehir, Turkey.
Förderung
- Research Projects Coordination Unit of Kırşehir Ahi Evran University
Zitieren
APA
Çiçek, Z., & Gürsoy, G. (2026). Investigation of the effects of 1α,25-dihydroxyvitamin D3–supplemented electrochemotherapy on apoptosis and PI3K/PKC/NF-κB signaling pathway protein levels: an in vitro experimental study. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03493-2
Vancouver
Çiçek Z, Gürsoy G. Investigation of the effects of 1α,25-dihydroxyvitamin D3–supplemented electrochemotherapy on apoptosis and PI3K/PKC/NF-κB signaling pathway protein levels: an in vitro experimental study. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03493-2
BibTeX
@article{iek2026,
author = {Çiçek, Zehra and Gürsoy, Güney},
title = {Investigation of the effects of 1α,25-dihydroxyvitamin D3–supplemented electrochemotherapy on apoptosis and PI3K/PKC/NF-κB signaling pathway protein levels: an in vitro experimental study},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03493-2}
}
EUVIMED